Abstract
The new coronavirus (SARS-COV2), which causes coronavirus illness, has expanded globally, impacting millions of individuals. In comparison to female patients, males have a higher prevalence, morbidity, and death rate from this condition, according to international statistics. Androgens have been implicated in the pathophysiology of COVID-19. This review's objective is to explain the potential connection between the pathophysiology of androgen and the infectivity mechanism of the coronavirus as well as the association between SARS-COV2 and hair disorders. This might assist in clarifying androgen's involvement in COVID-19 prognosis and therapy.